Anfield Capital Management’s iShares US Medical Devices ETF IHI Stock Holding History

Anfield Capital Management’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.89M	Buy	54,231 +4,674	+9%	+$274K	0.8%	28
2025 Q4	$3.08M	Buy	49,557 +49,489	+72,778%	+$3.06M	0.97%	22
2025 Q3	$4.08K	Sell	68 -2	-3%	-$122	﹤0.01%	425
2025 Q2	$4.38K	Buy	+70	New	+$4.21K	﹤0.01%	380

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Anfield Capital Management's IHI Position: Q1 2026 in Review

Anfield Capital Management increased its iShares US Medical Devices ETF (IHI) stake by 9.4% in Q1 2026, buying an estimated $274K and bringing the position to 54,231 shares worth $2.89M. The position accounts for 0.8% of the portfolio, ranked #28.

Anfield Capital Management first reported a position in IHI in Q2 2025 and has held it in 4 quarters since. The position peaked at $3.08M in Q4 2025. 509 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

Anfield Capital Management held 54,231 shares of iShares US Medical Devices ETF worth $2.89M as of Q1 2026.
Anfield Capital Management bought 4,674 iShares US Medical Devices ETF shares in Q1 2026, an estimated $274K.
iShares US Medical Devices ETF made up 0.8% of Anfield Capital Management's portfolio in Q1 2026, its #28 holding.
Anfield Capital Management first reported a position in iShares US Medical Devices ETF in Q2 2025 and has held it in 4 quarters since.
Anfield Capital Management's iShares US Medical Devices ETF position peaked at $3.08M in Q4 2025.
509 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Anfield Capital Management's 13F filing for Q1 2026, filed 12 May 2026.